1887

n CME : Your SA Journal of CPD - Human papillomavirus (HPV) vaccines : more about... best of 2011

Volume 30, Issue 1
  • ISSN : 0256-2170
USD

 

Abstract

Currently, two prophylactic HPV vaccines are available commercially (Table I). Cervarix (GlaxoSmithKline Biologicals) is a bivalent vaccine and Gardasil (Merck & Co) is a quadrivalent vaccine. HPV genotypes 16 and 18 currently contribute to approximately 70% of cervical cancer cases.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_cme/30/1/EJC64054
2012-01-01
2016-12-09

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error